Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to -$463.1 million.

  • Pediatrix Medical's Enterprise Value fell 11006.89% to -$463.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$463.1 million, marking a year-over-year decrease of 11006.89%. This contributed to the annual value of -$348.5 million for FY2024, which is 9607.3% down from last year.
  • Pediatrix Medical's Enterprise Value amounted to -$463.1 million in Q3 2025, which was down 11006.89% from -$348.3 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Enterprise Value ranged from a high of -$96.8 million in Q1 2022 and a low of -$486.9 million during Q4 2021
  • Moreover, its 5-year median value for Enterprise Value was -$177.7 million (2023), whereas its average is -$237.8 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first soared by 7883.29% in 2022, then tumbled by 16151.19% in 2025.
  • Pediatrix Medical's Enterprise Value (Quarter) stood at -$486.9 million in 2021, then skyrocketed by 78.83% to -$103.1 million in 2022, then plummeted by 72.46% to -$177.7 million in 2023, then tumbled by 96.07% to -$348.5 million in 2024, then plummeted by 32.88% to -$463.1 million in 2025.
  • Its Enterprise Value stands at -$463.1 million for Q3 2025, versus -$348.3 million for Q2 2025 and -$219.2 million for Q1 2025.